Drug interactions
Lamivudine + Ublituximab
Severity: Minor
Lamivudine and Ublituximab: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ublituximab causes B-cell depletion with infection risk and can reactivate hepatitis B. Lamivudine is used as HBV prophylaxis or treatment, so the pairing is relevant but is not a pharmacological interaction that reduces lamivudine activity.
What this interaction means in plain words
Lamivudine and Ublituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Lamivudine belongs to Anti Virals; Ublituximab belongs to Miscellaneous.
Why it happens
No direct pharmacokinetic interaction; ublituximab-related immunosuppression is independent of lamivudine.
What to do
Test for HBV before ublituximab and continue antiviral prophylaxis as indicated; monitor for infections and HBV markers.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Lamivudine and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Lamivudine
Other interactions of Ublituximab
Frequently asked questions
Can I take Lamivudine with Ublituximab?
MediHelp rates the interaction as minor. Lamivudine and Ublituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ublituximab causes B-cell depletion with infection risk and can reactivate hepatitis B. Lamivudine is used as HBV prophylaxis or treatment, so the pairing is relevant but is not a pharmacological interaction that reduces lamivudine activity.
How serious is the interaction between Lamivudine and Ublituximab?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Test for HBV before ublituximab and continue antiviral prophylaxis as indicated; monitor for infections and HBV markers.
What other medicines interact with Lamivudine?
MediHelp also lists interactions of Lamivudine with, for example, Elvitegravir / cobicistat / emtricitabine / tenofovir df, Atidarsagene autotemcel, Betibeglogene autotemcel. The full list is on the Lamivudine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
